Zeitschrift für Parasitenkunde

, Volume 70, Issue 3, pp 385–389 | Cite as

Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole

  • B. Gottstein
  • J Eckert
  • W. Woodtli
Original Investigations

Abstract

Parasite-specific immunoglobulin classes were determined by the ELISA in sera of 19 patients with cystic or alveolar echinococcosis before and after 2 years (±4 months) of continuous treatment with mebendazole at daily doses of 35–50 mg/kg body weight. In the majority of cases IgG decreased and IgA and IgE decreased or disappeared. In contrast, four patients with progressive disease showed reverse tendencies with increasing IgG, IgA and IgE concentrations during the same period.

Keywords

Body Weight Progressive Disease Continuous Treatment Echinococcosis Reverse Tendency 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ammann R, Akovbiantz A, Eckert J, Lagardier F (1979) Therapie der Echinokokkose. Dtsch Med Wochenschr 104:1429–1431Google Scholar
  2. Dessaint J-P, Capron A (1982) Radioimmunoassays and related procedures in seroepidemiology and diagnosis of parasitic disease. In: Capron A (ed) Clinics in immunology and allergy 2. Saunders Co., London, pp 655–666Google Scholar
  3. Eckert J, Barandun G, Pohlenz J (1978) Chemotherapie der larvalen Echinokokkose bei Labortieren. Schweiz Med Wochenschr 108:1104–1112Google Scholar
  4. Engvall E, Perlman P (1972) Enzyme-linked immunosorbent assay, ELISA III. J Immunol 109:129–135Google Scholar
  5. Gottstein B (1983) Isolation of an antigen fraction fromEchinococcus multilocularis with high species-specificity in ELISA and its identification with the Western-Blotting technique. In: Avrameas S, Druet P, Masseyeff R, Feldmann G (eds) Immunoenzymatic techniques. Elsevier, Amsterdam, pp 299–302Google Scholar
  6. Gottstein B, Eckert J, Fey H (1983) Serological differentiation betweenEchinococcus granulosus andE. multilocularis infections in man. Z Parasitenkd 69:347–356Google Scholar
  7. Kern P (1983) Human echinococcosis: follow-up of 23 patients treated with mebendazole. Infection 11:17–24Google Scholar
  8. Löscher T (1983) Der Radioallergosorbenttest (RAST) in der Diagnostik und Therapiekontrolle der Echinokokkose. Abstract no. 80, Tagung Tropenmed Ges, 21.–23.4.83, Garmisch-Partenkirchen orMichiels M, Hendriks R, Thijssen J, Heykants J (1978) A sensitive radioimmunoassay for mebendazole (R 17635) and flubendazole (R 17889). Janssen Research Products Information Service. Preclinical Research Reports R 17635/11 and R 17889/9Google Scholar
  9. Müller E, Akovbiantz A, Ammann RW, Bircher J, Eckert J, Wissler K, Witassek F, Wüthrich B (1982) Treatment of human echinococcosis with mebendazole. Hepatogastroenterology 29:236–239Google Scholar
  10. Ozeretskovskaya NN, Tumolkskaya NI, Poverenny AM, Serov VV, Podgorodnitschenko VK, Sivakov AE (1979) The role of the spleen in the origin of some clinical and immunological features of alveococcosis and echinococcosis. In: The role of the spleen in the immunology of parasitic diseases. Trop Dis Res Series No. 1, Schwabe and Co., Basel, pp 259–269Google Scholar
  11. Schantz PM, Van den Bossche H, Eckert J (1982) Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd 67:5–26Google Scholar
  12. WHO (1981) Treatment of human echinococcosis. Report of an informal meeting. PDP/82.1., GenevaGoogle Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • B. Gottstein
    • 1
  • J Eckert
    • 1
  • W. Woodtli
    • 2
  1. 1.Department of ParasitologyUniversity of ZürichZürichSwitzerland
  2. 2.Hospital of NeumünsterZollikerbergSwitzerland

Personalised recommendations